ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
•02 Oct 2026 10:56•Broker

SET Index Outlook

Electronics stocks are supported by easing US Treasury yields. Chinese refiners will suspend oil-product exports in October to preserve domestic...

Logo
94 Views
Share
bearish•SciSparc
•05 Aug 2026 06:01

Primer: SciSparc (SPRC US) - Aug 2026

SciSparc is a clinical-stage pharmaceutical company focused on developing cannabinoid-based therapies for central nervous system (CNS)...

Logo
111 Views
Share
•30 Sep 2026 10:48•Broker

SET Index Outlook

Markets are pricing in a lower probability of an October Fed rate hike as the US labor market weakens and consumer confidence plunges, supporting...

Logo
88 Views
Share
•03 Sep 2026 10:50•Broker

Krungthai XSpring Zoom Eng. September 3, 2026

The 10-year US Treasury yield eased to 4.78% as markets lowered the probability of a Fed rate hike in September following weak employment...

Logo
95 Views
Share
•18 Aug 2026 11:14•Broker

Krungthai XSpring Zoom Eng. August 18, 2026

Brent crude rose more than 2% amid concerns that tensions in the Middle East could persist, supporting speculative trading in energy stocks...

Logo
98 Views
Share
x